Promoter-specific induction of the phosphatase SHP-1 by viral infection and cytokines in CNS glia

Journal of Neurochemistry

Volumn 105, Issue 6, 2008, Pages 2511-2523

  Christophi, George P ^a   Hudson, Chad A ^a   Gruber, Ross ^a   Christophi, Christoforos P ^a   Massa, Paul T ^a,b  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Demyelination; Interferons; Multiple sclerosis; Protein tyrosine phosphatase; Signal transducers and activators of transcription; Theiler's murine encephalomyelitis virus

Indexed keywords

CYTOKINE; PROTEIN TYROSINE PHOSPHATASE SHP 1; STAT1 PROTEIN; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; GLIA; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTION;

ANIMALS; CARDIOVIRUS INFECTIONS; CELLS, CULTURED; CYTOKINES; ENCEPHALITIS, VIRAL; ENZYME INDUCTION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, VIRAL; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; NEUROGLIA; PROMOTER REGIONS, GENETIC; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; THEILOVIRUS;

MUS; THEILER'S ENCEPHALOMYELITIS VIRUS;

EID: 44649108263     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05337.x     Document Type: Article

References (47)

1. Ann Marrie R. Rudick R. A. (2006) Drug insight: interferon treatment in multiple sclerosis. Nat. Clin. Pract. Neurol. 2, 34 44.
2. Arnett H. A., Hellendall R. P., Matsushima G. K., Suzuki K., Laubach V. E., Sherman P. Ting J. P. (2002) The protective role of nitric oxide in a neurotoxicant-induced demyelinating model. J. Immunol. 168, 427 433.
3. Banville D., Stocco R. Shen S. H. (1995) Human protein tyrosine phosphatase 1C (PTPN6) gene structure: alternate promoter usage and exon skipping generate multiple transcripts. Genomics 27, 165 173.
4. Bonaparte K. L., Hudson C. A., Wu C. Massa P. T. (2006) Inverse regulation of inducible nitric oxide synthase (iNOS) and arginase I by the protein tyrosine phosphatase SHP-1 in CNS glia. Glia 53, 827 835.
5. van Boxel-Dezaire A. H., Rani M. R. Stark G. R. (2006) Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25, 361 372.
6. Cannella B. Raine C. S. (2004) Multiple sclerosis: cytokine receptors on oligodendrocytes predict innate regulation. Ann. Neurol. 55, 46 57.
7. Christophi G. P., Isackson P. J., Blaber S., Blaber M., Rodriguez M. Scarisbrick I. A. (2004) Distinct promoters regulate tissue-specific and differential expression of kallikrein 6 in CNS demyelinating disease. J. Neurochem. 91, 1439 1449.
8. Christophi G. P., Hudson C. A., Gruber R. C., Christophi C. P., Mihai C., Mejico L. J., Jubelt B. Massa P. T. (2008) SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients. Lab. Invest. 88, 243 255.
9. Ckless K., van der Vliet A. Janssen-Heininger Y. (2007) Oxidative-nitrosative stress and post-translational protein modifications: implications to lung structure-function relations. Arginase modulates NF-kappaB activity via a nitric oxide-dependent mechanism. Am. J. Respir. Cell Mol. Biol. 36, 645 653.
10. David M., Chen H. E., Goelz S., Larner A. C. Neel B. G. (1995) Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol. Cell. Biol. 15, 7050 7058.
11. Deng C., Minguela A., Hussain R. Z., Lovett-Racke A. E., Radu C., Ward E. S. Racke M. K. (2002) Expression of the tyrosine phosphatase SRC homology 2 domain-containing protein tyrosine phosphatase 1 determines T cell activation threshold and severity of experimental autoimmune encephalomyelitis. J. Immunol. 168, 4511 4518.
12. Eggert M., Goertsches R., Seeck U., Dilk S., Neeck G. Zettl U. K. (2008) Changes in the activation level of NF-kappa B in lymphocytes of MS patients during glucocorticoid pulse therapy. J. Neurol. Sci. 264, 145 150.
13. Frank C., Burkhardt C., Imhof D., Ringel J., Zschornig O., Wieligmann K., Zacharias M. Bohmer F. D. (2004) Effective dephosphorylation of Src substrates by SHP-1. J. Biol. Chem. 279, 11375 11383.
14. Frisullo G., Angelucci F., Caggiula M., Nociti V., Iorio R., Patanella A. K., Sancricca C., Mirabella M., Tonali P. A. Batocchi A. P. (2006) pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity. J. Neurosci. Res. 84, 1027 1036.
15. Gerhauser I., Ulrich R., Alldinger S. Baumgartner W. (2007) Induction of activator protein-1 and nuclear factor-kappaB as a prerequisite for disease development in susceptible SJL/J mice after theiler murine encephalomyelitis. J. Neuropathol. Exp. Neurol. 66, 809 818.
16. Gobin S. J., Montagne L., Van Zutphen M., Van Der Valk P., Van Den Elsen P. J. De Groot C. J. (2001) Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions. Glia 36, 68 77.
17. Hanson E. M., Dickensheets H., Qu C. K., Donnelly R. P. Keegan A. D. (2003) Regulation of the dephosphorylation of Stat6. Participation of Tyr-713 in the interleukin-4 receptor alpha, the tyrosine phosphatase SHP-1, and the proteasome. J. Biol. Chem. 278, 3903 3911.
18. Haque S. J., Harbor P., Tabrizi M., Yi T. Williams B. R. (1998) Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction. J. Biol. Chem. 273, 33893 33896.
19. Hudson C. A., Christophi G. P., Cao L., Gruber R. C. Massa P. T. (2006) Regulation of avoidant behaviours and pain by the anti-inflammatory tyrosine phosphatase SHP-1. Neuron Glia Biol. 2, 235 246.
20. Javed A. Reder A. T. (2006) Therapeutic role of beta-interferons in multiple sclerosis. Pharmacol. Ther. 110, 35 56.
21. Jin Y. J., Yu C. L. Burakoff S. J. (1999) Human 70-kDa SHP-1L differs from 68-kDa SHP-1 in its C-terminal structure and catalytic activity. J. Biol. Chem. 274, 28301 28307.
22. Kinkel R. P., Kollman C., O'Connor P. et al. (2006) IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event. Neurology 66, 678 684.
23. Marsh H. N., Dubreuil C. I., Quevedo C. et al. (2003) SHP-1 negatively regulates neuronal survival by functioning as a TrkA phosphatase. J. Cell Biol. 163, 999 1010.
24. Martin A., Tsui H. W., Shulman M. J., Isenman D. Tsui F. W. (1999) Murine SHP-1 splice variants with altered Src homology 2 (SH2) domains. Implications for the SH2-mediated intramolecular regulation of SHP-1. J. Biol. Chem. 274, 21725 21734.
25. Massa P. T. Wu C. (1996a) The role of protein tyrosine phosphatase SHP-1 in the regulation of IFN-gamma signaling in neural cells. J. Immunol. 157, 5139 5144.
26. Massa P. T. Wu C. (1996b) Modulation of major histocompatibility complex class I genes by interferon-gamma and ganglioside GT 1b in astrocytes: involvement of protein tyrosine phosphatases. J. Neurochem. 67, 1831 1839.
27. Massa P. T. Wu C. (1998) Increased inducible activation of NF-kappaB and responsive genes in astrocytes deficient in the protein tyrosine phosphatase SHP-1. J. Interferon Cytokine Res. 18, 499 507.
28. Massa P. T., Dorries R. ter Meulen V. (1986) Viral particles induce Ia antigen expression on astrocytes. Nature 320, 543 546.
29. Massa P. T., Saha S., Wu C. Jarosinski K. W. (2000) Expression and function of the protein tyrosine phosphatase SHP-1 in oligodendrocytes. Glia 29, 376 385.
30. Massa P. T., Ropka S. L., Saha S., Fecenko K. L. Beuler K. L. (2002) Critical role for protein tyrosine phosphatase SHP-1 in controlling infection of central nervous system glia and demyelination by Theiler's murine encephalomyelitis virus. J. Virol. 76, 8335 8346.
31. Massa P. T., Wu C. Fecenko-Tacka K. (2004) Dysmyelination and reduced myelin basic protein gene expression by oligodendrocytes of SHP-1-deficient mice. J. Neurosci. Res. 77, 15 25.
32. McCarthy M. de Vellis J. (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. The Journal of Cell Biology 85, 890 902.
33. Oka T., Yoshino T., Hayashi K. et al. (2001) Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias : combination analysis with cDNA expression array and tissue microarray. Am. J. Pathol. 159, 1495 1505.
34. Paling N. R. Welham M. J. (2002) Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling. Biochem. J. 368, 885 894.
35. Platanias L. C. (2005) Mechanisms of type-I- and type-II-interferon- mediated signalling. Nat. Rev. Immunol. 5, 375 386.
36. Rudick R. A., Lee J. C., Simon J., Ransohoff R. M. Fisher E. (2004) Defining interferon beta response status in multiple sclerosis patients. Ann. Neurol. 56, 548 555.
37. Scarisbrick I. A., Blaber S. I., Tingling J. T., Rodriguez M., Blaber M. Christophi G. P. (2006) Potential scope of action of tissue kallikreins in CNS immune-mediated disease. J. Neuroimmunol. 178, 167 176.
38. Takeda K., Noguchi K., Shi W., Tanaka T., Matsumoto M., Yoshida N., Kishimoto T. Akira S. (1997) Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl Acad. Sci. USA 94, 3801 3804.
39. Teige I., Treschow A., Teige A., Mattsson R., Navikas V., Leanderson T., Holmdahl R. Issazadeh-Navikas S. (2003) IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J. Immunol. 170, 4776 4784.
40. Tsui H. W., Hasselblatt K., Martin A., Mok S. C. Tsui F. W. (2002) Molecular mechanisms underlying SHP-1 gene expression. Eur. J. Biochem. 269, 3057 3064.
41. Wlodarski P., Zhang Q., Liu X., Kasprzycka M., Marzec M. Wasik M. A. (2007) PU.1 activates transcription of SHP-1 gene in hematopoietic cells. J. Biol. Chem. 282, 6316 6323.
42. Wu C., Sun M., Liu L. Zhou G. W. (2003) The function of the protein tyrosine phosphatase SHP-1 in cancer. Gene 306, 1 12.
43. Xu Y., Banville D., Zhao H. F., Zhao X. Shen S. H. (2001) Transcriptional activity of the SHP-1 gene in MCF7 cells is differentially regulated by binding of NF-Y factor to two distinct CCAAT-elements. Gene 269, 141 153.
44. Yarilina A., DiCarlo E. Ivashkiv L. B. (2007) Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs. J. Immunol. 178, 2204 2211.
45. Zeis T., Graumann U., Reynolds R. Schaeren-Wiemers N. (2007) Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain 131, 288 303.
46. Zhang Q., Raghunath P. N., Vonderheid E., Odum N. Wasik M. A. (2000) Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter. Am. J. Pathol. 157, 1137 1146.
47. Zhang Q., Wang H. Y., Marzec M., Raghunath P. N., Nagasawa T. Wasik M. A. (2005) STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. Proc. Natl Acad. Sci. USA 102, 6948 6953.